NEW YORK (TheStreet) -- Shares of Natus Medical Inc. (BABY) are surging, up 6.60% to $26.00, after the healthcare products company reported financial results for the 2014 first quarter ending March 31.
Revenue was $85.6 million, compared to $85.8 million in the first quarter of 2013.
Net income was $6.3 million, or $0.19 per diluted share, compared with net income of $3.4 million, or $0.11 per diluted share, in the first quarter of last year.
Natus said it reported record first quarter non-GAAP earnings per share of $0.26 per diluted share, up 73% from the $0.15 per diluted share reported for the first quarter of 2013.
TheStreet Ratings team rates NATUS MEDICAL INC as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate NATUS MEDICAL INC (BABY) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook."